Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Those holding Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) shares would be relieved that the share price has rebounded 25% in the last thirty days, but it needs to keep going to repair the re

Simply Wall StMar 19 19:05 ET

Xuerong Biology (300511.SZ)'s edible fungus products are generally sold around production bases, radiating surrounding areas

Gelonghui March 19 | Xuerong Biotech (300511.SZ) said on the investor interactive platform that the company currently has eight major domestic production bases: Changchun, Jilin, Dezhou, Guangdong, Dujiangyan, Sichuan, Bijie, Guizhou, Linyi, Gansu, Guigang, Guangxi, and Huai'an, Jiangsu. The company's edible fungus products are generally sold around production bases and surrounding areas.

Gelonghui FinanceMar 19 03:37 ET

Xuerong Biotech (300511.SZ): Plans to use capital raising related claims to increase capital for wholly-owned subsidiaries

Gelonghui, Feb. 23, 丨 Xuerong Biotech (300511.SZ) announced that the company increased its capital at RMB 1 yuan/share through debt-for-share swaps of 170 million yuan in part of the debt raised against its wholly-owned subsidiary Guangxi Xuerong Biotechnology Co., Ltd. (“Guangxi Xuerong”). After the capital increase is completed, the registered capital of Guangxi Xuerong will increase from 10 million yuan to 270 million yuan, and it is still a wholly-owned subsidiary of the company.

Gelonghui FinanceFeb 23 04:47 ET

Revenues Working Against Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Share Price Following 26% Dive

Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) shareholders that were waiting for something to happen have been dealt a blow with a 26% share price drop in the last month. The drop over the

Simply Wall StFeb 2 17:16 ET

Xuerong Biotech (300511.SZ) and related personnel accepted the Shanghai Securities Regulatory Bureau's administrative supervision measures decision

Xuerong Biotech (300511.SZ) issued an announcement. The company received the Shanghai Securities Regulatory Bureau on December 25, 2023...

Zhitong FinanceDec 25, 2023 07:33 ET

Xuerong Biotech (300511.SZ): Net loss of 169 million yuan in the third quarter

On October 27, Gelonghui Biotech (300511.SZ) announced its report for the third quarter of 2023. Operating income for the reporting period was 569 million yuan, a year-on-year decrease of 15.86%; net profit attributable to shareholders of listed companies was -169 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was -172 million yuan; and basic earnings per share was -0.34 yuan.

Gelonghui FinanceOct 27, 2023 11:26 ET